Mind Medicine MindMed Inc.

About Mind Medicine MindMed Inc.

MindMed is a company focused on rethinking brain health through transformational innovation. They aim to develop an industry-leading, evidence-based pipeline of product candidates to transform the treatment landscape for brain health disorders, addressing unmet patient needs in conditions like Generalized Anxiety Disorder (GAD), Major Depressive Disorder (MDD), and Autism Spectrum Disorder (ASD) using psychedelics and novel compounds.

Products & Services

MM120 ODT:A product candidate for the treatment of Generalized Anxiety Disorder (GAD) and Major Depressive Disorder (MDD).

MM402:A product candidate targeting Autism Spectrum Disorder (ASD).

Research & Development Pipeline:A range of programs exploring novel treatments for various brain health disorders across diverse therapeutic areas and mechanisms of action.

Specialties

Brain Health Disorders Psychedelic Therapies Generalized Anxiety Disorder (GAD) Major Depressive Disorder (MDD) Autism Spectrum Disorder (ASD) Novel Compound Development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 259000000 MR: - FA: approximately $259 million FAN: 259000000	D: 2025-10-31 FD: 2025-10-31	5 investors
2	RT: Public Offering T: - FT: Public Offering	A: 225000000 MR: - FA: 225 million FAN: 225000000	D: 2025-10-29 FD: 2025-10-29	5 investors
3	RT: Public Offering T: - FT: Public Offering	A: 75000000 MR: - FA: approximately $75 million FAN: 75000000	D: 2024-08-09 FD: 2024-08-09	4 investors
4	RT: Private placement T: - FT: Private placement	A: 175000000 MR: - FA: 175 million dollars FAN: 175000000	D: 2024-03-20 FD: 2024-03-20	-
5	RT: Underwritten Offering and Private Placement T: - FT: Underwritten Offering and Private Placement	A: 175000000 MR: - FA: approximately $175 million FAN: 175000000	D: 2024-03-07 FD: 2024-03-07	12 investors
6	RT: Debt T: - FT: Debt	A: 50000000 MR: - FA: $50.0 million FAN: 50000000	D: 2023-08-14 FD: 2023-08-14	1 investors

Public Offering Latest

2025-10-31

$259.0M

5 investors (Pro only)

Public Offering 2025-10-29

$225.0M

Public Offering 2024-08-09

$75.0M

View 5 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News